251 related articles for article (PubMed ID: 27343180)
1. The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer's Disease Pathogenesis.
Moncini S; Lunghi M; Valmadre A; Grasso M; Del Vescovo V; Riva P; Denti MA; Venturin M
Mol Neurobiol; 2017 Aug; 54(6):4329-4342. PubMed ID: 27343180
[TBL] [Abstract][Full Text] [Related]
2. Multiple Layers of
Spreafico M; Grillo B; Rusconi F; Battaglioli E; Venturin M
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29997370
[TBL] [Abstract][Full Text] [Related]
3. The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration.
Moncini S; Salvi A; Zuccotti P; Viero G; Quattrone A; Barlati S; De Petro G; Venturin M; Riva P
PLoS One; 2011; 6(5):e20038. PubMed ID: 21625387
[TBL] [Abstract][Full Text] [Related]
4. hnRNPA2/B1 and nELAV proteins bind to a specific U-rich element in CDK5R1 3'-UTR and oppositely regulate its expression.
Zuccotti P; Colombrita C; Moncini S; Barbieri A; Lunghi M; Gelfi C; De Palma S; Nicolin A; Ratti A; Venturin M; Riva P
Biochim Biophys Acta; 2014 Jun; 1839(6):506-16. PubMed ID: 24792867
[TBL] [Abstract][Full Text] [Related]
5. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
7. Cloning and spatio-temporal expression of porcine CDK5 and CDK5R1(p35) genes.
Long H; Zhao S; Lei T; Han J; Yuan J; Qi Y; Yang Z
Anim Biotechnol; 2009; 20(3):133-43. PubMed ID: 19544209
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.
Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
Mol Med Rep; 2015 Aug; 12(2):3081-8. PubMed ID: 25955795
[TBL] [Abstract][Full Text] [Related]
9. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.
Wang WX; Rajeev BW; Stromberg AJ; Ren N; Tang G; Huang Q; Rigoutsos I; Nelson PT
J Neurosci; 2008 Jan; 28(5):1213-23. PubMed ID: 18234899
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.
Long JM; Ray B; Lahiri DK
J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696
[TBL] [Abstract][Full Text] [Related]
11. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
12. Expression of amyloid-associated miRNAs in both the forebrain cortex and hippocampus of middle-aged rat.
Che H; Sun LH; Guo F; Niu HF; Su XL; Bao YN; Fu ZD; Liu HL; Hou X; Yang BF; Ai J
Cell Physiol Biochem; 2014; 33(1):11-22. PubMed ID: 24401368
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1.
Zhu HC; Wang LM; Wang M; Song B; Tan S; Teng JF; Duan DX
Brain Res Bull; 2012 Sep; 88(6):596-601. PubMed ID: 22721728
[TBL] [Abstract][Full Text] [Related]
14. Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease.
Sadleir KR; Vassar R
J Biol Chem; 2012 Mar; 287(10):7224-35. PubMed ID: 22223639
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease.
Song WJ; Son MY; Lee HW; Seo H; Kim JH; Chung SH
PLoS One; 2015; 10(8):e0136950. PubMed ID: 26317805
[TBL] [Abstract][Full Text] [Related]
16. miR-186 is decreased in aged brain and suppresses BACE1 expression.
Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
[TBL] [Abstract][Full Text] [Related]
17. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
Li J; Wang H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
[TBL] [Abstract][Full Text] [Related]
18. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability.
Moncini S; Castronovo P; Murgia A; Russo S; Bedeschi MF; Lunghi M; Selicorni A; Bonati MT; Riva P; Venturin M
J Hum Genet; 2016 Apr; 61(4):283-93. PubMed ID: 26657932
[TBL] [Abstract][Full Text] [Related]
20. Research status of the regulation of miRNA on BACE1.
Deng Y; Ding Y; Hou D
Int J Neurosci; 2014 Jul; 124(7):474-7. PubMed ID: 24147552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
